Vaidya Sane Ayurved Laboratories Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Vaidya Sane Ayurved Laboratories Limited's yearly results (2023–2026), compared with companies in India. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 8% in 3 years; of every extra ₹100 of sales, ₹54 became extra profit. Higher than 92% of companies in India.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 13% of its market value (net cash). Higher than 91% of companies in India.
- Tangible Assets Ratio: Of every ₹100 the company owns, ₹88 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 87% of companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹165Over the last 3 years, every ₹100 of reported profit came with ₹165 of operating cash.
Higher than 80% of companies in India.
Self-Funding Ratio
1.1×Over the last 3 years its own operating cash covered its investment spending (capex) 1.1 times.
Lower than 52% of companies in India.
Cash Locked Ratio
₹6For every ₹100 of sales, ₹6 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹3 from others' credit three years earlier.
Less money tied up than 79% of companies in India.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Less steady than 58% of companies in India.
Growth Efficiency Ratio
₹54Sales grew 8% in 3 years; of every extra ₹100 of sales, ₹54 became extra profit.
Higher than 92% of companies in India.
Asset Productivity Ratio
+8% / +90%In 3 years sales changed by +8% while total assets changed by +90%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
+13%Cash, after subtracting all debt, equals 13% of its market value (net cash).
Higher than 91% of companies in India.
Tangible Assets Ratio
88%Of every ₹100 the company owns, ₹88 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 87% of companies in India.
Tangible Net Worth Ratio
86%Of every ₹100 of net worth, ₹86 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 83% of companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Vaidya Sane Ayurved Laboratories Limited owes ₹0.16 for every ₹1 it owns. Net profit rose 26% in the year to Mar 2026, and grew 23% a year on average over 3 years.
Compared with companies in India · latest annual results Mar 2026.
P/E ratio
18.4Investors pay ₹18.4 for every ₹1 of Vaidya Sane Ayurved Laboratories Limited's yearly profit, lower than 60% of companies in India.
P/B ratio
1.76The share price is 1.76 times Vaidya Sane Ayurved Laboratories Limited's book value per share, lower than 60% of companies in India.
Market cap
₹154 CrThe total market value of all of Vaidya Sane Ayurved Laboratories Limited's shares at today's price (share price × number of shares), smaller than 84% of companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹87 CrWhat Vaidya Sane Ayurved Laboratories Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹83.03Net worth divided by the number of shares. The share price of ₹146.45 is 1.8 times this, which is the P/B above.
Owes vs Owns
0.16×Vaidya Sane Ayurved Laboratories Limited owes ₹0.16 for every ₹1 it owns (low), lower than 89% of companies in India.
Revenue growth
+19%Revenue rose 19% in the year to Mar 2026, and grew 3% a year on average over 3 years.
Profit growth
+26%Net profit rose 26% in the year to Mar 2026, and grew 23% a year on average over 3 years.
Profit margin
8.4%Vaidya Sane Ayurved Laboratories Limited keeps ₹8 of every ₹100 of revenue as net profit.
Cash quality
0.6×Cash from Vaidya Sane Ayurved Laboratories Limited's business was 0.6× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
61.7×Vaidya Sane Ayurved Laboratories Limited's operating profit covered its interest costs 61.7 times in the year to Mar 2026.
Cash vs debt
Net cashVaidya Sane Ayurved Laboratories Limited held ₹20 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Vaidya Sane Ayurved Laboratories Limited's P/E ratio?
Investors pay ₹18.4 for every ₹1 of Vaidya Sane Ayurved Laboratories Limited's yearly profit, lower than 60% of companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Vaidya Sane Ayurved Laboratories Limited: ₹154 Cr ÷ ₹87 Cr (31 Mar 2026) = 1.8.
How much does Vaidya Sane Ayurved Laboratories Limited owe compared with what it owns?
Vaidya Sane Ayurved Laboratories Limited owes ₹0.16 for every ₹1 it owns (low), lower than 89% of companies in India.
Is Vaidya Sane Ayurved Laboratories Limited's revenue growing?
Revenue rose 19% in the year to Mar 2026, and grew 3% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.